Advanced Infusion Management System

Publication ID: 24-11857762_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Advanced Infusion Management System,” Published Technical Disclosure No. 24-11857762_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857762_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,762.

Summary of the Inventive Concept

A next-generation infusion management system that leverages AI, machine learning, and advanced sensing technologies to provide real-time monitoring, autonomous control, and precision fluid delivery in various medical settings.

Background and Problem Solved

The original patent for integrated liquid flow closed loop sensing and control addressed the need for accurate flow rate monitoring in infusion processes. However, it has limitations in terms of adaptability, scalability, and patient-centric care. The new inventive concept builds upon the original idea, overcoming these limitations by introducing advanced technologies that enable real-time patient data integration, autonomous infusion therapy, and decentralized data management.

Detailed Description of the Inventive Concept

The Advanced Infusion Management System comprises a machine learning-based flow control module that dynamically adjusts infusion rates based on real-time patient data and fluid viscosity measurements. The system utilizes artificial intelligence to predict and prevent infusion-related complications, such as over-infusion or under-infusion. It incorporates wearable or implantable devices with MEMS flow sensors, enabling real-time monitoring and control of fluid flow rates in ambulatory patients. The system also features a decentralized infusion management platform with a blockchain-based data storage system, securely recording and sharing patient infusion data among healthcare providers and institutions.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift in infusion management by integrating AI, machine learning, and advanced sensing technologies to provide real-time monitoring, autonomous control, and precision fluid delivery. The use of machine learning-based flow control, artificial intelligence-driven complication prediction, and decentralized data management via blockchain technology are novel and non-obvious advancements over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the Advanced Infusion Management System could include the use of different AI algorithms, various types of sensors, or alternative data storage systems. The system could also be adapted for use in different medical settings, such as in-home care or emergency response situations.

Potential Commercial Applications and Market

The Advanced Infusion Management System has significant commercial potential in the healthcare industry, particularly in the areas of hospital care, home healthcare, and pharmaceutical research. The system's ability to provide real-time monitoring, autonomous control, and precision fluid delivery could improve patient outcomes, reduce healthcare costs, and enhance the overall efficiency of infusion therapy.

CPC Classifications

SectionClassGroup
A A61 A61M5/172
A A61 A61M2205/3334
A A61 A61M2205/3584
A A61 A61M2205/52
H H01 H01R13/15
H H01 H01R2201/12
H H01 H01R2201/20
H H02 H02J50/10

Field of Art

Medical device engineering, specifically infusion systems and fluid delivery technologies, with expertise in electronic sensing, control systems, and medical device integration

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, 3-5 years experience in medical device design, familiar with microfluidic sensing, electronic control systems, and regulatory compliance for medical devices

Obviousness Rationale

A PHOSITA would recognize that the Advanced Infusion Management System represents predictable technological extensions of the source patent's core concepts of integrated flow sensing and control. The machine learning and AI-driven approaches are natural progressions of existing closed-loop sensing technologies. The additional features like blockchain data management and MEMS sensors represent incremental improvements using known techniques in adjacent technological domains.

Obvious Combinations & Variations

Source Patent Element
Electronic flow sensor with data communication component and conductive connections
PTD Variation
MEMS flow sensors with real-time monitoring and AI-driven data processing
Obviousness Reasoning
Predictable application of miniaturization and machine learning techniques to existing flow sensing technologies, representing an obvious design optimization
Source Patent Element
Infusion device with control circuitry for modifying flow rates
PTD Variation
Machine learning-based flow control module dynamically adjusting infusion rates
Obviousness Reasoning
Known technique of applying adaptive control algorithms to existing flow regulation systems, producing expected improvements in precision and responsiveness
Source Patent Element
Tubing fitment with flow stop mechanism
PTD Variation
Nanoscale flow control valve with bio-compatible power source for targeted drug delivery
Obviousness Reasoning
Logical extension of existing flow control principles using miniaturization techniques common in medical device engineering
Source Patent Element
Integrated IV administration set with electronic communication
PTD Variation
Blockchain-based decentralized data management platform for patient infusion records
Obviousness Reasoning
Obvious application of emerging data management technologies to existing medical device communication frameworks
35 U.S.C. § 103 Summary: In view of US Patent 11857762, the disclosed Advanced Infusion Management System represents obvious variations to a Person Having Ordinary Skill In The Art, combining known techniques in machine learning, sensor technologies, and medical device design to produce predictable improvements in fluid delivery and monitoring systems. The technological variations would be readily apparent to a skilled practitioner as straightforward extensions of existing closed-loop sensing and control methodologies.

Original Patent Information

Patent NumberUS 11,857,762
TitleIntegrated liquid flow closed loop sensing and control
Assignee(s)CareFusion 303, Inc.